Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad Halwani, Christopher R. Flowers, Iris Isufi et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 20